Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FlexBoardTM, EagleBoardTM, BreastBoard SXTM

K-Number: K213439 · 2022-06-24

Decision Date2022-06-24
Product CodeIYE
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

FlexBoardTM, EagleBoardTM, BreastBoard SXTM is the device name listed in this FDA 510(k) record. The listed applicant is Macromedics BV. It received FDA 510(k) clearance on 2022-06-24 under 510(k) number K213439. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FlexBoardTM, EagleBoardTM, BreastBoard SXTM?

FlexBoardTM, EagleBoardTM, BreastBoard SXTM is a medical device that received FDA 510(k) clearance on 2022-06-24. The listed applicant is Macromedics BV. The 510(k) number is K213439.

When did FlexBoardTM, EagleBoardTM, BreastBoard SXTM receive FDA 510(k) clearance?

FlexBoardTM, EagleBoardTM, BreastBoard SXTM received FDA 510(k) clearance on 2022-06-24, under 510(k) number K213439.

Who is the listed applicant for FlexBoardTM, EagleBoardTM, BreastBoard SXTM?

The FDA 510(k) record lists Macromedics BV as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FlexBoardTM, EagleBoardTM, BreastBoard SXTM?

The FDA product code for FlexBoardTM, EagleBoardTM, BreastBoard SXTM is IYE.

Other records listing Macromedics BV as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: IYE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.